Digital Health Insights

Equity

Equitable Diagnostics: Closing the Access Divide for All

Equitable distribution of diagnostics and medicines requires deliberate redesign of supply chains and clinic workflows to reach populations historically left behind.

2026-10-20 · Dr Vas editorial

The shift

Health systems are moving from centralized procurement models toward distributed networks that prioritize underserved regions for both point-of-care tests and essential medicines. This change recognizes that concentration of stock in urban hubs creates predictable shortages farther out. Operators now map patient travel times and disease burden together so that rapid antigen kits or first-line antihypertensives arrive where incidence is rising fastest. The shift also includes shared forecasting between public facilities and private pharmacies so that one sector’s surplus can offset another’s shortfall without new tenders. Clinicians see the practical effect in fewer same-day referrals simply because a basic panel or starter pack is missing. Over time the pattern reduces the need for patients to absorb transport costs or lose wages while chasing supplies. The underlying principle is that equity is measured not by total volume purchased but by the reduction in days a clinic reports zero stock of priority items. This requires routine data loops between frontline staff and district stores rather than annual bulk orders alone.

How it works in clinic

In daily practice a nurse or physician logs current inventory through a shared dashboard before the morning list begins. When projected demand for a malaria rapid test or oral rehydration salts exceeds on-site supply, the system flags the nearest hub for same-day transfer. Medicines follow the same pathway: a three-day course of antibiotics is reserved for confirmed cases rather than held in reserve for walk-ins who may never return. Diagnostic devices are rotated on fixed schedules so that a glucometer or ultrasound probe spends equal weeks at each linked site. Staff training focuses on interpreting results with limited follow-up options, such as initiating treatment when confirmatory imaging is days away. Documentation captures not only what was used but why a test was deferred, creating a record that informs the next quarter’s allocation. The workflow keeps decision-making with the clinician while the logistics layer handles movement and replenishment.

Who pays

Payment responsibility sits with a mix of national health budgets, regional risk pools, and targeted donor commitments that cover only the gap between forecasted need and locally generated revenue. Facilities contribute a fixed percentage of their reimbursement for insured patients into a redistribution fund that purchases stock for the uninsured. This avoids creating separate parallel supply chains that fragment quality. Private wholesalers participate through volume guarantees that stabilize prices when public tenders fall short. The model requires transparent reporting of margins so that no single payer absorbs repeated losses from expired lots. When a district reports consistent under-ordering, the fund adjusts future contributions rather than penalizing the clinic. The result is that cost is distributed according to capacity while access remains tied to clinical indication instead of ability to pay at the point of service.

Where it fails

Failures appear most clearly when data systems are not updated in real time or when transport contracts lack penalties for missed rural deliveries. A clinic may correctly forecast a surge in respiratory panels yet receive the shipment after the peak has passed because the carrier prioritizes higher-volume urban routes. Another breakdown occurs when diagnostic devices arrive without compatible reagents, leaving staff with hardware but no consumables for weeks. Equity also erodes when training is limited to initial rollout and does not cover staff turnover, so new clinicians revert to older referral patterns. Stock visibility gaps between public and private outlets allow leakage where medicines intended for free distribution appear in informal markets. These points of failure are usually visible in routine variance reports but require dedicated review time that many overburdened teams cannot schedule.

India’s public distribution network

India’s public distribution network for essential medicines and diagnostics offers a large-scale example of attempting equitable reach through state-level procurement and last-mile delivery via primary health centers. The system uses centralized rate contracts for common items such as HIV test kits and oral antibiotics, then routes stock through district warehouses to facilities based on reported consumption. Ayushman Bharat empaneled sites receive additional support for diagnostics under the Pradhan Mantri Jan Arogya Yojana, linking payment to verified service delivery. Challenges remain in states with weaker road infrastructure where monsoon disruptions regularly delay temperature-sensitive shipments. Some districts have introduced drone pilots for remote areas, yet scale remains limited. The network demonstrates that policy intent alone does not guarantee daily availability without continuous operational oversight at each node.

What to do this quarter

Map the three most common diagnostics and medicines that trigger external referrals from your clinic and calculate average patient wait time or travel distance for each. Establish a standing weekly call with the district store to review projected shortfalls before they become zero-stock events. Identify one neighboring facility that can serve as a reciprocal buffer for high-turnover items and formalize a simple exchange log. Review all device maintenance logs to confirm that any equipment currently idle has a scheduled rotation or repair plan within the next eight weeks. Finally, schedule a thirty-minute team debrief at month end to record which workflow changes reduced referral rates and which did not, then adjust the next month’s standing order accordingly.

Three moves

  • Audit current referral reasons tied to missing diagnostics or medicines and rank them by patient impact.
  • Set a standing weekly inventory review with the nearest hub and document every transfer.
  • Create one reciprocal stock-sharing agreement with a neighboring site before the quarter closes. Partner with LetsGo.Health to operationalize these equity steps at clinic scale.
Follow-through lives on LetsGo.Health.
Equitable Diagnostics: Closing the Access Divide for All | Dr. Vas Metupalle